MET and neoplasm: Additionally, numerous targets of expressions which were observed in carcinogenesis and tumor progression were reported to be regulated by miR-34a, such as CD44, BCL2, NOTCH1, CDK4/6, MET, MYC, and many other molecules (47, 48).